Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Mayo Clinic
Mayo Clinic
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
NRG Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)